Current Report Filing (8-k)
May 16 2016 - 5:48PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 13, 2016
THERMO FISHER SCIENTIFIC INC.
(Exact name of Registrant as specified in its Charter)
|
|
|
|
|
Delaware
|
|
1-8002
|
|
04-2209186
|
(State or other jurisdiction
of incorporation or organization)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification Number)
|
|
|
81 Wyman Street
Waltham, Massachusetts
|
|
02451
|
(Address of principal executive offices)
|
|
(Zip Code)
|
(781) 622-1000
(Registrants telephone number including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (
see
General Instruction A.2. below):
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 8.01 Other Events
On May 13, 2016, Life Technologies Corporation (the Company), a wholly-owned subsidiary of Thermo Fisher Scientific Inc. (Thermo
Fisher) entered into a settlement agreement (the Settlement Agreement) with Enzo Life Sciences, Inc. (Enzo) with respect to an action brought by Enzo against the Company on January 30, 2012, in the United States
District Court for the District of Delaware, alleging patent infringement by the Companys TaqMan
®
probes and assays, Dynabead
®
oligo-dT beads, NCode oligonucleotide array products, Ion Torrent beads and chips and SOLiD beads and chips. Pursuant to the Settlement Agreement, the Company agreed to pay Enzo $35 million (the Settlement Amount)
and Enzo released the Company from past damages and granted the Company a license to the asserted patent families on products sold by the Company and its affiliates. The case will be dismissed after the Company pays the Settlement
Amount. The Settlement Amount was fully reserved in Thermo Fishers consolidated financial statements at April 2, 2016.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized, on this 16th day of May, 2016.
|
|
|
THERMO FISHER SCIENTIFIC INC.
|
|
|
By:
|
|
/s/ Seth H. Hoogasian
|
|
|
Seth H. Hoogasian
Senior Vice President,
General Counsel and Secretary
|
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Apr 2023 to Apr 2024